A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma

References

Page 1

	Year	Citations
New Guidelines to Evaluate the Response to Treatment in Solid Tumors Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer, JNCI Journal of the National Cancer Institute World Health OrganizationSolid TumorsCancer ManagementMetronomic ChemotherapyResponse Assessment	2000	15.7K
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology N.K. Aaronson, Sam H. Ahmedzai, Bengt Bergman, JNCI Journal of the National Cancer Institute	1993	15.4K
TNM Classification of Malignant Tumours. Annals of Internal Medicine Tumor BiologyTumoral PathologyMedicineSurgical PathologyPathology	1969	1.1K
One-Sample Multiple Testing Procedure for Phase II Clinical Trials Thomas R. Fleming Biometrics Surgical OncologyClinical EndpointMetronomic ChemotherapyTranslational MedicineClinical Trials	1982	993
A Proposed New International TNM Staging System for Malignant Pleural Mesothelioma Valerie W. Rusch CHEST Journal Malignant Pleural MesotheliomaMedicineSurgical PathologyPathologyPleural Effusion	1995	605
Continuing increase in mesothelioma mortality in Britain Julian Peto, Fiona E. Matthews, J T Hodgson, The Lancet OncologyMesothelioma MortalityCancer RegistrationEpidemiology	1995	573
Gemcitabine Plus Vinorelbine Versus Vinorelbine Alone in Elderly Patients With Advanced Non–Small-Cell Lung Cancer G. Frasci, Vito Lorusso, Nicola Panza, Journal of Clinical Oncology	2000	452
Cisplatin and Gemcitabine Treatment for Malignant Mesothelioma: A Phase II Study Michael Byrne, Jennifer Davidson, Arthur W. Musk, Journal of Clinical Oncology	1999	335
Interaction between cisplatin and gemcitabine in vitro and in vivo. Godefridus J. Peters, Andries M. Bergman, V W Ruiz van Haperen, PubMed	1995	314
Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study. Lucio Crinò, Giorgio V. Scagliotti, M. Marangolo, Journal of Clinical Oncology	1997	306

Page 1